Bedside optical coherence tomography for Terson's syndrome screening in acute subarachnoid hemorrhage: a pilot study.
Acute Disease
Adult
Affect
Aged, 80 and over
Ambulatory Surgical Procedures
Blindness
/ etiology
Cerebral Angiography
Cerebral Ventricles
/ diagnostic imaging
Female
Follow-Up Studies
Humans
Incidence
Inpatients
Male
Middle Aged
Pilot Projects
Point-of-Care Testing
Prospective Studies
Quality of Life
Subarachnoid Hemorrhage
/ complications
Tomography, Optical Coherence
/ methods
Treatment Outcome
Vision, Ocular
Vitreous Hemorrhage
/ diagnostic imaging
GCS = Glasgow Coma Scale
H&H = Hunt and Hess
HDS = Hamilton Depression Scale
ILM = inner limiting membrane
IVH = intraventricular hemorrhage
NIH-PROMIS = NIH Patient-Reported Outcomes Measurement Information System
OCT = optical coherence tomography
PHQ-9 = Patient Health Questionnaire–depression module
SAH = subarachnoid hemorrhage
TS = Terson’s syndrome
Terson’s syndrome
VFQ-25 = 25-item National Eye Institute Visual Functioning Questionnaire
aSAH = acute SAH
diagnosis
diagnostic technique
mRS = modified Rankin Scale
optic coherence tomography
subarachnoid hemorrhage
vascular disorders
Journal
Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
30
05
2017
accepted:
24
07
2017
pubmed:
3
2
2018
medline:
19
10
2019
entrez:
3
2
2018
Statut:
ppublish
Résumé
Approximately 10% of patients with subarachnoid hemorrhage (SAH) become permanently, legally blind.
The average cost of lifetime support and unpaid taxes for each blind person amounts to approximately $900,000. This study evaluates the feasibility and potential role of bedside optical coherence tomography (OCT) in Terson’s syndrome (TS) in patients with acute SAH (aSAH) and its potential role in blindness prevention. The authors conducted an open-label pilot study, in which 31 patients with an angiographic diagnosis of
aSAH were first screened for TS with dilated funduscopy and then with OCT in the acute phase and at 6-week followup visits. Outpatient mood assessments (Patient Health Questionnaire–depression module, Hamilton Depression Scale), and quality of life general (NIH Patient-Reported Outcomes Measurement Information System) and visual scales (25-item National Eye Institute Visual Functioning Questionnaire) were measured at 1 and 6 weeks after discharge. Exclusion criteria included current or previous history of severe cataracts, severe diabetic retinopathy, severe macular degeneration, or glaucoma. OCT identified 7 patients with TS, i.e., a 22.6% incidence in our aSAH sample: 7 in the acute phase, including a large retinal detachment that was initially missed by funduscopy and diagnosed by OCT in follow-up clinic. Dilated retinal funduscopy significantly failed to detect TS in 4 (57.1%) of these 7 cases. Intraventricular hemorrhage was significantly more common in TS cases (85.7% vs 25%). None of the participants experienced any complications from OCT examinations. Neither decreased quality of life visual scale scores nor a depressed mood correlated with objective OCT pathological findings at the 6-week follow-up after discharge. There were no significant mood differences between TS
cases and controls. OCT is the gold standard in retinal disease diagnosis. This pilot study shows that bedside OCT examination
is feasible in aSAH. In this series, OCT was a safe procedure that enhanced TS detection by decreasing
false-negative/inconclusive funduscopic examinations. It allows early diagnosis of macular holes and severe retinal detachments, which require acute surgical therapy to prevent legal blindness. In addition, OCT aids in ruling out potential false-positive visual deficits in individuals with a depressed mood at follow-up.
Identifiants
pubmed: 29393753
doi: 10.3171/2017.7.JNS171302
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM